Drug class
Adrenergic beta-Antagonists clinical trials
A class of medicines: the studies that test any of its 27 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.
Keep track of what changes. Save the adrenergic beta-antagonists studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesMedicines in this class
Studies that test each. A study of two counts under both, and once above.
- Brimonidine Tartrate, Timolol Maleate Drug Combination
- 11
- Bevantolol
- 2
- Levobetaxolol
- 2
- Arotinolol
- 2
- Talinolol
- 2
- Timolol Maleate Gel Forming Solution
- 1
- Bucindolol
- 1
- Carteolol
- 1
- Bunitrolol hydrochloride
- 1
- Vemtoberant
- 1
Studies by the year they started
990 studies that test it; most in 2010 (65); 1 more planned to start later
| Year | Studies |
|---|---|
| 1992 | 1 |
| 1993 | 2 |
| 1994 | 2 |
| 1995 | 1 |
| 1996 | 3 |
| 1997 | 3 |
| 1998 | 4 |
| 1999 | 6 |
| 2000 | 8 |
| 2001 | 17 |
| 2002 | 17 |
| 2003 | 16 |
| 2004 | 16 |
| 2005 | 31 |
| 2006 | 28 |
| 2007 | 44 |
| 2008 | 40 |
| 2009 | 48 |
| 2010 | 65 |
| 2011 | 42 |
| 2012 | 44 |
| 2013 | 36 |
| 2014 | 42 |
| 2015 | 47 |
| 2016 | 43 |
| 2017 | 42 |
| 2018 | 43 |
| 2019 | 39 |
| 2020 | 35 |
| 2021 | 48 |
| 2022 | 31 |
| 2023 | 32 |
| 2024 | 41 |
| 2025 | 42 |
| 2026 | 31 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
- Hypertension
- 106
- Glaucoma
- 36
Who runs them
Industry 192 · Other 809
Allergan (12) · Ain Shams University (11) · Forest Laboratories (11) · Institute of Liver and Biliary Sciences, India (10) · Merck KGaA, Darmstadt, Germany (10) · GlaxoSmithKline (10) · Weill Medical College of Cornell University (9) · Mylan Bertek Pharmaceuticals (9)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.
Testing one of them · 1,001
- Beta-blocker Administration for Cardiomyocyte DivisionRecruitingPhase 1Weill Medical College of Cornell UniversityNCT04713657Written as Propranolol Hydrochloride
- Non-selective Beta-blocker in Compensated Advanced Chronic Liver DiseaseRecruitingPhase 4Chinese University of Hong KongNCT06449339Written as Carvedilol
- Propranolol With Chemotherapy or Chemoradiation for Esophageal AdenocarcinomaRecruitingPhase 2Roswell Park Cancer InstituteNCT04682158Written as Propranolol
- Propranolol Hydrochloride Combined With Toripalimab and Platinum-based Chemotherapy in Resectable Non-Small Cell Lung CancerRecruitingPhase 1Second Xiangya Hospital of Central South UniversityNCT07886229Written as Propranolol Hydrochloride
- Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung CancerRecruitingPhase 1Second Xiangya Hospital of Central South UniversityNCT07886047Written as Propranolol Hydrochloride
- Impact of Beta Blockers on TAVI (BETA-TAVI)RecruitingPhase 4National and Kapodistrian University of AthensNCT05721170Written as Beta blocker
- Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison StudyRecruitingPhase 4Mayo ClinicNCT06972056Written as Propranolol 160 mg
- Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)Enrolling by invitationPhase 4Weill Medical College of Cornell UniversityNCT07298993Written as Beta-blockers
- Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic ScoreRecruitingPhase 4University of MichiganNCT07490067Written as Metoprolol Succinate
- The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label TrialNot yet recruitingPhase 2Geisinger ClinicNCT07583862Written as Topical Timolol
- STunning in Acute Myocardial Infarction - BASRecruitingPhase 4Vastra Gotaland RegionNCT06562582Written as Bisoprolol Oral Tablet
- CSP #2026 - Beta Blocker Dialyzability on Cardiovascular OutcomesRecruitingPhase 3VA Office of Research and DevelopmentNCT05931276Written as Metoprolol Succinate
- Topical 0.5% Timolol Solution for Healing Lower Extremity WoundsRecruitingPhase 1Icahn School of Medicine at Mount SinaiNCT06941467Written as Timolol Maleate Solution
- Effect of Labetalol, Magnesium Sulfate, or Lidocaine on Opioid Consumption During Laparoscopic CholecystectomyNot yet recruitingPhase 4Assiut UniversityNCT07865455Written as Labetalol
- Efficacy of Cognitive Behavioral Therapy at Vestibular MigraineNot yet recruitingNot applicableSohag UniversityNCT07849283Written as •Group A: Patients will receive Medical treatment only: Beta-blockers (Propranolol) , Calcium channel blockers
- A Study of Propranolol to Treat Kaposi SarcomaRecruitingPhase 2AIDS Malignancy ConsortiumNCT05797662Written as Propranolol
- Esmolol Versus Dexmedetomidine for Opioid-sparing in Laparoscopic Gynecological SurgeryRecruitingNot applicableVasiliki SamartziNCT07846722Written as Esmolol hydrochloride
- Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular CancerNot yet recruitingPhase 2University of Southern CaliforniaNCT07836712Written as Propranolol
- Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile HemangiomaRecruitingPhase 2/3West China HospitalNCT06798363Written as propranolol
- Premedication With Atenolol Versus Metoprolol for Controlled Hypotensive Anesthesia During Nasal SurgeriesRecruitingPhase 4Damanhour Teaching HospitalNCT04914234Written as Atenolol Succinate Oral Tablet
See all 1,001 studies that test one of the adrenergic beta-antagonists →
Codes
What other systems call Adrenergic beta-Antagonists · ClinicalTrials.gg INT006911
- MeSH (NLM) D000319Adrenergic beta-AntagonistsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000319 | Adrenergic beta-Antagonists | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.